Replies to post #102210 on Amarin Corp Plc (AMRN)

[Pyrrhonian]

Wellllllllll

FDA could not approve (as final approval) generics if the case will be still ongoing, they could give conditional approval only. If Amarin will win the patent case (more likely, see below AZN case) generic could not be sold. --HD

Not true? Yes not true.

NCE was extended 5 years after AMRN won a court battle overturning FDA's 3 year NCE protection. Under this NCE FDA will not approve any ANDAs (generics). Once it's up, they can and will. It's up July 2017 (5 years from 2012 approval). And then generics producers will file ANDAs (watch, it will happen this summer). Then AMRN will file suit. Then it gets another 30 month stay. That's all they can get. Jan 2020, it's all over.

I've watched this stuff happen a number of times and, generics guys always win :)

Regardless of R-IT success or failure, AMRN only has until 2020 (or maybe a LITTLE after) to milk as much out of sales as they can. Meanwhile if R-IT fails, say hi to $0.50 ;)

Cheers

[BaaBaa45]

I think we should have some sort of handicapping system.... This isn't a fair fight. Funny though.......